220 related articles for article (PubMed ID: 29876940)
1. Cost-effectiveness analysis of imaging strategy for an intensive follow-up of patients with American Joint Committee on Cancer stage IIB, IIC and III malignant melanoma.
Podlipnik S; Moreno-Ramírez D; Carrera C; Barreiro A; Manubens E; Ferrandiz-Pulido L; Sánchez M; Vidal-Sicart S; Malvehy J; Puig S
Br J Dermatol; 2019 May; 180(5):1190-1197. PubMed ID: 29876940
[TBL] [Abstract][Full Text] [Related]
2. Findings of computed tomography in stage IIB and IIC melanoma: a six-year retrospective study in the South-East of Scotland.
Orfaniotis G; Mennie JC; Fairbairn N; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Sep; 65(9):1216-9. PubMed ID: 22525255
[TBL] [Abstract][Full Text] [Related]
3. Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH
J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057
[TBL] [Abstract][Full Text] [Related]
4. Does staging computered tomography change management in thick malignant melanoma?
Sawyer A; McGoldrick RB; Mackey SP; Allan R; Powell B
J Plast Reconstr Aesthet Surg; 2009 Apr; 62(4):453-6. PubMed ID: 18468970
[TBL] [Abstract][Full Text] [Related]
5. The MELFO Study: A Multicenter, Prospective, Randomized Clinical Trial on the Effects of a Reduced Stage-Adjusted Follow-Up Schedule on Cutaneous Melanoma IB-IIC Patients-Results After 3 Years.
Deckers EA; Hoekstra-Weebers JEHM; Damude S; Francken AB; Ter Meulen S; Bastiaannet E; Hoekstra HJ
Ann Surg Oncol; 2020 May; 27(5):1407-1417. PubMed ID: 31535302
[TBL] [Abstract][Full Text] [Related]
6. Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort study.
Podlipnik S; Carrera C; Sánchez M; Arguis P; Olondo ML; Vilana R; Rull R; Vidal-Sicart S; Vilalta A; Conill C; Malvehy J; Puig S
J Am Acad Dermatol; 2016 Sep; 75(3):516-524. PubMed ID: 27183845
[TBL] [Abstract][Full Text] [Related]
7. The role of routine imaging in pediatric cutaneous melanoma.
Halalsheh H; Kaste SC; Navid F; Bahrami A; Shulkin BL; Rao B; Kunkel M; Artz N; Pappo A
Pediatr Blood Cancer; 2018 Dec; 65(12):e27412. PubMed ID: 30124237
[TBL] [Abstract][Full Text] [Related]
8. Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.
Lee AY; Droppelmann N; Panageas KS; Zhou Q; Ariyan CE; Brady MS; Chapman PB; Coit DG
Ann Surg Oncol; 2017 Apr; 24(4):939-946. PubMed ID: 27804026
[TBL] [Abstract][Full Text] [Related]
9.
Jaeger ZJ; Williams GA; Chen L; Mhlanga JC; Cornelius LA; Fields RC
J Surg Oncol; 2022 Mar; 125(3):525-534. PubMed ID: 34741547
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of surveillance of stage I melanoma. A retrospective appraisal based on a 10-year experience in a dermatology department in France.
Bassères N; Grob JJ; Richard MA; Thirion X; Zarour H; Noe C; Collet-Vilette AM; Lota I; Bonerandi JJ
Dermatology; 1995; 191(3):199-203. PubMed ID: 8534937
[TBL] [Abstract][Full Text] [Related]
11. The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients-Results after 1 Year.
Damude S; Hoekstra-Weebers JE; Francken AB; Ter Meulen S; Bastiaannet E; Hoekstra HJ
Ann Surg Oncol; 2016 Sep; 23(9):2762-71. PubMed ID: 27194552
[TBL] [Abstract][Full Text] [Related]
12. The significance of imaging examinations during follow-up for malignant melanoma.
Pozsgai M; Németh K; Oláh P; Gyulai R; Lengyel Z
Eur J Dermatol; 2021 Jun; 31(3):357-363. PubMed ID: 34309521
[TBL] [Abstract][Full Text] [Related]
13. [Impact of whole body magnetic resonance imaging (MRI) in the management of melanoma patients, in comparison with positron emission tomography/computed tomography (TEP/CT) and CT].
Dellestable P; Granel-Brocard F; Rat AC; Olivier P; Régent D; Schmutz JL
Ann Dermatol Venereol; 2011 May; 138(5):377-83. PubMed ID: 21570561
[TBL] [Abstract][Full Text] [Related]
14. Role of computed tomography in the staging of patients with local-regional metastases of melanoma.
Buzaid AC; Tinoco L; Ross MI; Legha SS; Benjamin RS
J Clin Oncol; 1995 Aug; 13(8):2104-8. PubMed ID: 7636554
[TBL] [Abstract][Full Text] [Related]
15. Utility of 3-year torso computed tomography and head imaging in asymptomatic patients with high-risk melanoma.
DeRose ER; Pleet A; Wang W; Seery VJ; Lee MY; Renzi S; Sullivan RJ; Atkins MB
Melanoma Res; 2011 Aug; 21(4):364-9. PubMed ID: 21540750
[TBL] [Abstract][Full Text] [Related]
16. Computed tomography in evaluation of patients with stage III melanoma.
Kuvshinoff BW; Kurtz C; Coit DG
Ann Surg Oncol; 1997; 4(3):252-8. PubMed ID: 9142387
[TBL] [Abstract][Full Text] [Related]
17. The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence.
Abbott RA; Acland KM; Harries M; O'Doherty M
Melanoma Res; 2011 Oct; 21(5):446-9. PubMed ID: 21849913
[TBL] [Abstract][Full Text] [Related]
18. Whole body PET/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma
Koskivuo I; Kemppainen J; Giordano S; Seppänen M; Veräjänkorva E; Vihinen P; Minn H
Acta Oncol; 2016 Nov; 55(11):1355-1359. PubMed ID: 27553064
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of imaging studies for initial staging of T2b to T4b melanoma patients: A cross-sectional study.
Riquelme-Mc Loughlin C; Podlipnik S; Bosch-Amate X; Riera-Monroig J; Barreiro A; Espinosa N; Moreno-Ramírez D; Giavedoni P; Vilana R; Sánchez M; Vidal-Sicart S; Carrera C; Malvehy J; Puig S
J Am Acad Dermatol; 2019 Dec; 81(6):1330-1338. PubMed ID: 31163236
[TBL] [Abstract][Full Text] [Related]
20. Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D Melanoma.
Turner RM; Dieng M; Khanna N; Nguyen M; Zeng J; Nijhuis AAG; Nieweg OE; Einstein AJ; Emmett L; Lord SJ; Menzies AM; Thompson JF; Saw RPM; Morton RL
Ann Surg Oncol; 2021 Aug; 28(8):4561-4569. PubMed ID: 33393039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
